Valeant’s deal with Ackman: Too clever to be legal? – CNBC

CNBC
Tiptoeing on a tightrope past insider trading laws may be deft and clever, but it doesn’t make it right. For months, William A. Ackman, the hedge fund manager, has nonchalantly said, repeatedly, that his purchase of Allergan shares worth over $1 billion ahead …
UPDATE 1-Glass Lewis sides with Ackman on Allergan meeting requestReuters
Valeant’s Deal With Ackman May Be Too Clever to Be LegalNew York Times
Investor Bill Ackman continues racking up gainsNew York Post
Hedgeworld (subscription)NASDAQMSN Money
all 31 news articles

…read more

Source: Business News From Google News

Leave a Comment